References

AbuRahma AF, Boland JP, Witsberger T. Diagnostic and therapeutic strategies of white clot syndrome. Am J Surg 162:175-179, 1991.

Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lammle B. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med 114:528-536, 2003.

Anderegg BA, Baillie GM, Lin A, Lazarchick J. Heparin-induced thrombocytopenia in a renal transplant recipient. Am J Transplant 5:1537-1540, 2005.

Anderson KC, Kihajda FP, Bell WR. Diagnosis and treatment of anticoagulant-related adrenal hemorrhage. Am J Hematol 11:379-385, 1981.

Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R, Khambalia B. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 89:321-326,1992.

Ansell JE, Clark WP Jr, Compton CC. Fatal reactions associated with intravenous heparin [letter]. Drug Intell Clin Pharm 20:74-75, 1986.

Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355:809-817, 2006.

Arthur CK, Grant SJB, Murray WK, Isbister JP, Stiel JN, Lauer CS. Heparin-associated acute adrenal insufficiency. Aust NZ J Med 15:454-455, 1985.

Ayala E, McDonough RF, Morgensztern D, Kharfan-Dabaja MA, Byrnes JJ. Heparin-induced thrombocytopenia presenting with thrombosis of multiple saphenous vein grafts (abstr). Blood (suppl):3894, 2002.

Balestra B, Quadri P, Demarmels Biasiutti F, Furlan M, Lammle B. Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites. Eur J Haematol 53:61-63, 1994.

Beland B, Busse H, Loick HM, Ostermann H, van Aken H. Phlegmasia cerulea dolens, cerebral venous thrombosis, and fatal pulmonary embolism due to heparin-induced thrombocytopenic thrombosis syndrome. Anesth Analg 85:1272-1274, 1997.

Benhamou AC, Gruel Y, Barsotti J, Castellani L, Marchand M, Guerois C, Leclerc MH, Delahousse B, Griguer P, Leroy J. The white clot syndrome or heparin-associated thrombocytopenia and thrombosis (WCS or HATT). Int Angiol 4:303-310, 1985.

Bernasconi F, Metivet F, Estrade G, Garnier D, Donatien Y. Thrombose d'une pros-thèse valvulaire mitrale au cours d'une thrombopénie induite par l'héparine. Traitement fibrinolytique Presse Méd 17:1366, 1988.

Betrosian AP, Theodossiades G, Lambroulis G, Kostantonis D, Balla M, Papanikolaou M, Georgiades G. Heparin-induced thrombocytopenia with pulmonary embolism and disseminated intravascular coagulation associated with low-molecular-weight heparin. Am J Med Sci 325:45-47, 2003.

Bircher AJ, Fluckiger R, Buchner S A. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 123:507-514, 1990.

Bircher AJ, Itin PH, Buchner SA. Skin lesions, hypereosinophilia, and subcutaneous heparin [letter]. Lancet 343:861, 1994.

Bleasel JF, Rasko JEJ, Rickard KA, Richards G. Acute adrenal insufficiency secondary to heparin-induced thrombocytopenia-thrombosis syndrome. Med J Aust 157: 192-193, 1992.

Bode AP, Castellani WJ, Hodges ED, Yelverton S. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT). Thromb Haemost 66:213-217, 1991.

Boshkov LK, Warkentin TE, Hayward CPM, Andrew M, Kelton JG. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 84:322-328,1993.

Bowers MJ, Jones FGC. Thrombus in harvested marrow from a patient with recent heparin-induced thrombocytopenia. Br J Haematol 119:294, 2002.

Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG. Protein C and the development of skin necrosis during anticoagulant therapy [letter]. Thromb Haemost 49:251, 1983.

Brushwood DB. Hospital liable for allergic reaction to heparin used in injection flush. Am J Hosp Pharm 49:1491-1492, 1992.

Bürger T, Tautenhahn J, Bock M, Fahlke J, Halloul Z, Lippert H. Can a coated Dacron vascular graft maintain a heparin-induced thrombocytopenia type II? Langenbecks Arch Surg 386:267-271, 2001.

Butler TJ, Sodoma LJ, Doski JJ, Cheu HW, Berg ST, Stokes GN, Lancaster KJ. Heparin-associated thrombocytopenia and thrombosis as the cause of a fatal thrombus on extracorporeal membrane oxygenation. J Pediatr Surg 32:768-771,1997.

Calhoun BC, Hesser JW. Heparin-associated antibody with pregnancy: discussion of two cases. Am J Obstet Gynecol 156:964-966, 1987.

Carette S, Jobin F. Acute adrenal insufficiency as a manifestation of the anticardiolipin syndrome? Ann Rheum Dis 48:430-431,1989.

Carlsson LE, Lubenow N, Blumentritt C, Kempf R, Papenberg S, Schroder W, Eichler P, Herrmann FH, Santoso S, Greinacher A. Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia. Pharmacogenetics 13:253-258, 2003.

Castaman G, Ruggeri M, Girardello R, Rodeghiero F. An unusually prolonged case of heparin-induced thrombocytopenia and disseminated intravascular coagulation. Haematologica 77:174-176, 1992.

Celoria GM, Steingart RH, Banson B, Friedmann P, Rhee SW, Berman JA. Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia—a case report. Angiology 39:915-920, 1988.

Cipolle RJ, Rodvoid KA, Seifert R, Clarens R, Ramirez-Lassepas M. Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients. Ther Drug Monit 5:205-211, 1983.

Cohen GR, Hall JC, Yeast JD, Field-Kriese D. Heparin-induced cutaneous necrosis in a postpartum patient. Obstet Gynecol 72:498-499, 1988.

Cohen DJ, Briggs R, Head HD, Acher CW. Phlegmasia cerulea dolens and its association with hypercoagulable states: case reports. Angiology 40:498-500, 1989.

Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis—a review of the literature. Surgery 103:271-277, 1988.

Commeau P, Grollier G, Charbonneau P, Troussard X, Lequerrec A, Bazin C, Potier JC. Thrombopénie immuno-allergique induite par l'héparine responsable d'une thrombose intraventriculaire gauche. Therapie 41:345-347, 1986.

Comp PC. Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance. Drug Safety 8:128-135, 1993.

Copeman PWM. Livedo reticularis. Signs in the skin of disturbance of blood viscosity and of blood flow. Br J Dermatol 93:519-522, 1975.

Copplestone A, Oscier DG. Heparin-induced thrombocytopenia in pregnancy [letter]. Br J Haematol 65:248,1987.

Cruz D, Karlsberg R, Takano Y, Vora D, Tobis J. Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia. Cathet Cardio-vasc Intervent 58:80-83, 2003.

Dahlberg PJ, Goellner MH, Pehling GB. Adrenal insufficiency secondary to adrenal hemorrhage. Two case reports and a review of cases confirmed by computed tomography. Arch Intern Med 150:905-909,1990.

Davey MG, Lander H. Effect of adenosine diphosphate on circulating platelets in man. Nature 201:1037-1039, 1964.

Delhumeau A, Granry JC. Heparin-associated thrombocytopenia [letter]. Crit Care Med 20:1192, 1992.

de Saint-Blanquat L, Simon L, Toubas MF, Hamza J. Traitement par le danaparoi'de de sodium au cours de la grossesse chez une patiente présentant une allergie cutanée aux héparines de bas poids moléculaire. Ann Fr Anesth Reanim 19:751-754, 2000.

Dion D, Dumesnil JG, LeBlanc P. In situ right ventricular thrombus secondary to heparin induced thrombocytopenia. Can J Cardiol 5:308-310,1989.

Drouet M, Le Pabic F, Le Sellin J, Bonneau JC, Sabbah A. Allergy to heparin. Special problems set by pregnant women. Allergol Immunopathol 20:225-229, 1992.

Dux S, Pitlik S, Perry G, Rosenfeld JB. Hypersensitivity reaction to chlorbutol-preserved heparin [letter]. Lancet 1:149, 1981.

Ernest D, Fisher MM. Heparin-induced thrombocytopenia complicated by bilateral adrenal haemorrhage. Intensive Care Med 17:238-240,1991.

Fausett MB, Vogtlander M, Lee RM, Esplin MS, Branch DW, Rodgers GM, Silver RM. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 185:148-152, 2001.

Feng WC, Singh AK, Bert AA, Sanofsky SJ, Crowley JP. Perioperative paraplegia and multiorgan failure from heparin-induced thrombocytopenia. Ann Thorac Surg 55:1555-1557, 1993.

Gaigl Z, Pfeuffer P, Raith P, Brocker EB, Trautmann A. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Br J Haematol 128:389-392, 2005.

Gallus AS, Goodall KT, Tillett J, Jackaman J, Wycherley A. The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism. Thromb Res 46:539-553,1987.

Ganzer D, Gutezeit A, Mayer G, Greinacher A, Eichler P. Thromboembolieprophylaxe als Ausloser thrombembolischer Komplikationen. Eine Untersuchung zur Inzidenz der Heparin-induzierten Thrombozytopenie (HIT) Typ II. Z Orthop Ihre Grenzgeb 135:543-549, 1997.

Gardyn J, Sorkin P, Kluger Y, Kabili S, Klausner JM, Zivelin A, Eldor A. Heparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance. Am J Hematol 50:292-295,1995.

Ginsberg JS, Brill-Edwards P, Burrows RF, Bona R, Prandoni P, Büller HR, Lensing A. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 67:519-520, 1992.

Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, Ramon R, Baggio G, Fabris F, Girolami A. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101:2955-2959, 2003.

Grasseger A, Fritsch P, Reider N. Delayed-type hypersensitivity and cross-reactivity to heparin and danaparoid: a prospective study. Dermatol Surg 27:47-52, 2001.

Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106:401-407, 2005.

Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost 67:545-549, 1992.

Greinacher A, Eckhardt T, Mussmann J, Mueller-Eckhardt C. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172). Thromb Res 71:123-126, 1993.

Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34:381-385,1994.

Greinacher A, Völpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, Mueller-Velten HG, Pötzsch B, for the HIT Investigators Group. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 99:73-80,1999.

Greinacher A, Eichler P, Lubenow N, Kwasny H, Luz M. Heparin-induced thrombocy-topenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96:846-851, 2000.

Greinacher A, Eichler P, Lietz T, Warkentin TE. Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia. Blood 106:2921-2922, 2005a.

Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 94:132-135, 2005b.

Gross AS, Thompson FL, Arzubiaga MC, Graber SE, Hammer RD, Schulman G, Ellis DL, King LE Jr. Heparin-associated thrombocytopenia and thrombosis (HATT) presenting with livedo reticularis. Int J Dermatol 32:276-279, 1993.

Gruel Y, Lang M, Darnige L, Pacouret G, Dreyfus X, Leroy J, Charbonnier B. Fatal effect of reexposure to heparin after previous heparin-associated thrombocytopenia and thrombosis [letter]. Lancet 336:1077-1078, 1990.

Gruel Y, Pouplard C, Nguyen P, Borg JY, Derlon A, Juhan-Vague I, Regnault V, Samama M. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol 121:786-792, 2003.

Gupta AK, Kovacs MJ, Sauder DN. Heparin-induced thrombocytopenia. Ann Pharmac-other 32:55-59, 1998.

Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B. Heparin-asso-ciated thrombosis despite normal platelet counts [letter]. Lancet 344:469-470,1994.

Hall AV, Clark WF, Parbtani A. Heparin-induced thrombocytopenia in renal failure. Clin Nephrol 38:86-89,1992.

Hall JC, McConahay D, Gibson D. Heparin necrosis. An anticoagulation syndrome. JAMA 244:1831-1832,1980.

Handschin AE, Trentz O, Kock HJ, Wanner GA. Low molecular weight heparin-induced skin necrosis—a systematic review. Langenbecks Arch Surg 390:249-254, 2005.

Hartman AR, Hood RM, Anagnostopoulos CE. Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis. J Vasc Surg 7:781-784,1988.

Hartman V, Malbrain M, Daelemans R, Meersman P, Zachee P. Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients: safety of resuming heparin after disappearance of HIT antibodies. Nephron Clin Pract 104:c143-c148, 2006 [epub ahead of print].

Hasegawa GR. Heparin-induced skin lesions. Drug Intell Clin Pharm 18:313-314,1984.

Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 331:625-628, 1994.

Hewitt RL, Akers DL, Leissinger CA, Gill JI, Aster RH. Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patients with heparin-induced antibodies. J Vasc Surg 28:561-565, 1998.

Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin. Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 114(suppl): 489S-510S, 1998.

Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119(suppl):64S-94S, 2001.

Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocy-topenia. Blood 101:3049-3051, 2003.

Hourigan LA, Walters DL, Keck SA, Dec GW. Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients. J Heart Lung Transplant 21: 1283-1289, 2002.

Houston DS. Heparin-induced thrombocytopenia without thrombocytopenia in a patient with essential thrombocythemia [letter]. Am J Hematol 65:331-332, 2000.

Hunter JB, Lonsdale RJ, Wenham PW, Frostick SP. Heparin-induced thrombosis: an important complication of heparin prophylaxis for thromboembolic disease in surgery. Br Med J 307:53-55, 1993.

Jackson MR, Neilson JW, Lary M, Baay P, Web K, Clagett GP. Delayed-onset heparin-induced thrombocytopenia and thrombosis after intraoperative heparin anticoagulation—four case reports. Vasc Endovasc Surg 40:67-70, 2006.

Jain A. Ischemic lumbosacral plexus neuropathy secondary to possible heparin-induced thrombosis following aortoiliac bypass [abstr]. Arch Phys Med Rehabil 67:680, 1986.

Jones BF, Epstein MT. Cutaneous heparin necrosis associated with glomerulonephritis. Australas J Dermatol 28:117-118, 1987.

Kappa JR, Fisher CA, Berkowitz HD, Cottrell ED, Addonizio VP Jr. Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management. J Vasc Surg 5:101-109,1987.

Kaufman BR, Zoldos J, Bentz M, Nystrom NA. Venous gangrene of the upper extremity. Ann Plast Surg 40:370-377, 1998.

Kearsley JH, Jeremy RW, Coates AS. Leukocytoclastic vasculitis and skin necrosis following subcutaneous heparin calcium. Aust NZ J Med 12:288-289, 1982.

Kelly RA, Gelfand JA, Pincus SH. Cutaneous necrosis caused by systemically administered heparin. JAMA 246:1582-1583, 1981.

Kelton JG, Meltzer D, Moore J, Giles AR, Wilson WE, Barr R, Hirsh J, Neame PB, Powers JP, Walker I, Bianchi F, Carter CJ. Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood 58:524-529, 1981.

Kerr TM, Cranley JJ, Johnson JR, Lutter KS, Riechmann GC, Cranley RD, True MA, Sampson M. Analysis of 1084 consecutive lower extremities involved with acute venous thrombosis diagnosed by duplex scanning. Surgery 108:520-527, 1990.

King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 100: 535-540, 1984.

Klein HG, Bell WR. Disseminated intravascular coagulation during heparin therapy. Ann Intern Med 80:477-481,1974.

Klement D, Rammos S, von Kries R, Kirschke W, Kniemeyer HW, Greinacher A. Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts. Eur J Pediatr 155:11-14, 1996.

Klenner AF, Fusch C, Rakow A, Kadow I, Beyersdorff E, Eichler P, Wander K, Lietz T, Greinacher A. Benefit and risk for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. J Pediatr 143:741-745, 2003.

Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytope-nia in children: 12 new cases and review of the literature. Thromb Haemost 91: 719-724, 2004.

Koch P, Bahmer FA, Schafer H. Tolerance of intravenous low-molecular-weight heparin after eczematous reaction to subcutaneous heparin. Contact Dermatitis 25:205-206, 1991.

Kovacs KA, Lam YM, Pater JL. Bilateral massive adrenal hemorrhage. Assessment of putative risk factors by the case-control method. Medicine (Balt) 80:45-53, 2001.

Kyritsis AP, Williams EC, Schutta HS. Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 21:1503-1505, 1990.

Laster J, Cikrit D, Waler N, Silver D. The heparin-induced thrombocytopenia syndrome: an update. Surgery 102:763-770, 1987.

Lee DH, Warkentin TE, Denomme GA, Lagrotteria DD, Kelton JG. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Thromb Haemost 79:50-53,1998.

Levine RL, Hursting MJ, Drexler A, Lewis BE, Francis JL. Heparin-induced thrombocy-topenia in the emergency department. Ann Emerg Med 44:511-515, 2004.

Levine RL, McCollum D, Hursting MJ. How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia? Chest 130:681-687, 2006.

Lewis BE, Wallis DE, Hursting MJ, Levine RL, Leya F. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Chest 129:1407-1416, 2006.

Lindhoff-Last E, Wenning B, Stein M, Gerdsen F, Bauersachs R, Wagner R. Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia. Clin Appl Thrombosis/Hemostasis 8:347-352, 2002.

Lindsey SM, Maddison FE, Towne JB. Heparin-induced thromboembolism: angio-graphic features. Radiology 131:771-774, 1979.

Ling E, Warkentin TE. Intraoperative heparin flushes and acute heparin-induced thrombocytopenia. Anesthesiology 89:1567-1569, 1998.

Lipton ME, Gould D. Case report: heparin-induced thrombocytopenia—a complication presenting to the vascular radiologist. Clin Radiol 45:137-138, 1992.

Liu JC, Lewis BE, Steen LH, Grassman ED, Bakhos M, Blakeman B, Wrona L, Leya F. Patency of coronary artery bypass grafts in patients with heparin-induced thrombo-cytopenia. Am J Cardiol 89:979-981, 2002.

Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 4:759-765, 2006.

Lubenow N, Kempf R, Eichner A, Eichler P, Carlsson LE, Greinacher A. Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin. Chest 122:37-42, 2002.

Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Wolf-Henning B. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb Haemost 94:1265-1269, 2005.

Ludwig RJ, Schindewolf M, Utikal J, Lindhoff-Last E, Boehnke WH. Management of cutaneous type IV hypersensitivity reactions induced by heparin. Thromb Haemost 96:611-617, 2006.

MacLean JA, Moscicki R, Bloch KJ. Adverse reactions to heparin. Ann Allerg 65: 254-259, 1990.

Makhoul RG, Greenberg CS, McCann RL. Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg 4:522-528, 1986.

Markel A, Manzo RA, Bergelin RO, Strandness DE Jr. Pattern and distribution of thrombi in acute venous thrombosis. Arch Surg 127:305-309, 1992.

Maurin N, Biniek R, Heintz B, Kierdorf H. Heparin-induced thrombocytopenia and thrombosis with spinal ischaemia—recovery of platelet count following a change to a low molecular weight heparin [letter]. Intensive Care Med 17:185-186,1991.

McKay DG. Late manifestations of intravascular coagulation—tissue necrosis. In: McKay DG, ed. Disseminated Intravascular Coagulation. An Intermediary Mechanism of Disease. New York: Harper & Row, pp. 392-471, 1965.

Meyer-Lindenberg A, Quenzel E-M, Bierhoff E, Wolff H, Schindler E, Biniek R. Fatal cerebral venous sinus thrombosis in heparin-induced thrombotic thrombocytopenia. Eur Neurol 37:191-192, 1997.

Meytes D, Ayalon H, Virag I, Weisbort Y, Zakut H. Heparin-induced thrombocytopenia and recurrent thrombosis in pregnancy. A case report. J Reprod Med 31: 993-996,1986.

Mims MP, Manian P, Rice L. Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia. Eur J Haematol 72:366-369, 2004.

Muntean W, Finding K, Gamillscheg A, Zenz W. Multiple thromboses and coumarin induced skin necrosis in a young child with antiphospholipid antibodies. Thromb Haemorrh Disord 5:43-45,1992.

Murdoch IA, Beattie RM, Silver DM. Heparin-induced thrombocytopenia in children. Acta Paediatr 82:495-497, 1993.

Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S. Heparin induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 56:12-16, 1997.

Natelson EA, Lynch EC, Alfrey CP Jr, Gross JB. Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy. Ann Intern Med 71:1121-1125, 1969.

Nelson JC, Lerner RG, Goldstein R, Cagin NA. Heparin-induced thrombocytopenia. Arch Intern Med 138:548-552,1978.

Newman PM, Chong BH. Further characterization of antibody and antigen in heparin-induced thrombocytopenia. Br J Haematol 107:303-309, 1999.

Nguyen QD, Do DV, Feke GT, Demirjian ZN, Lashkari K. Heparin induced anti-heparin platelet antibody associated with retinal venous thrombosis. Ophthalmology 110:600-603, 2003.

Odeh M, Oliven A. Urticaria and angioedema induced by low-molecular-weight heparin [letter]. Lancet 340:972-973, 1992.

Olbricht K, Wiersbitzky M, Wacke W, Eichler P, Zinke H, Schwock M, Mox B, Kraatz G, Motz W, Greinacher A. Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin). Blood Coagul Fibrinolysis 9:273-277, 1998.

Olinger GN, Hussey CV, Olive JA, Malik MI. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. J Thorac Cardio-vasc Surg 87:673-677, 1984.

Oriot D, Wolf M, Wood C, Brun P, Sidi D, Devictor D, Tchernia G, Huault G. Thrombopénie sévère induite par l'héparine chez un nourrisson porteur d'une myocardite aiguë. Arch Fr Pediatr 47:357-359, 1990.

Padilla A, Gray E, Pepper DS, Barrowcliffe TW. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4). Br J Haematol 82:406-413,1992.

Patriarca G, Rossi M, Schiavino D, Schinco G, Fais G, Varano C, Schiavello R. Rush desensitization in heparin hypersensitivity: a case report. Allergy 49:292-294, 1994.

Payne SM, Kovacs MJ. Cutaneous dalteparin reactions associated with antibodies of heparin-induced thrombocytopenia. Ann Pharmacother 37:655-658, 2003.

Pedersen-Bjergaard U, Andersen M, Hansen PB. Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 52:183-189, 1997.

Pfueller SL, David R, Firkin BG, Bilston RA, Cortizo F. Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombo-cytopenia. Br J Haematol 74:336-341,1990.

Phelan BK. Heparin-associated thrombosis without thrombocytopenia. Ann Intern Med 99:637-638, 1983.

Platell CFE, Tan EGC. Hypersensitivity reactions to heparin: delayed onset thrombocy-topenia and necrotizing skin lesions. Aust NZ J Surg 56:621-623, 1986.

Pohl C, Klockgether T, Greinacher A, Hanfland P. Harbrecht U. Neurological complications in heparin-induced thrombocytopenia. Lancet 353:1678-1679,1999.

Pohl C, Harbrecht U, Greinacher A, Theuerkaufl, Binick R, Hanfland P, Klockgether T. Neurologic complications in immune-mediated heparin-induced thrombocytopenia. Neurology 54:1240-1245, 2000.

Popov D, Zarrabi MH, Foda H, Graber M. Pseudopulmonary embolism: acute respiratory distress in the syndrome of heparin-induced thrombocytopenia. Ann J Kidney Dis 29:449-452, 1997.

Potter C. Gill JC, Scott JP, McFarland JG. Heparin-induced thrombocytopenia in a child. J Pediatr 121:135-138,1992.

Pötzsch B, Klövekorn WP, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia [letter]. N Engl J Med 343:515, 2000.

Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Ann J Clin Pathol 111:700-706, 1999.

Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 128:837-841, 2005.

Ramirez-Lassepas M, Cipolle RJ, Rodvold KA, Seifert RD, Strand L, Taddeini L, Cusulos M. Heparin-induced thrombocytopenia in patients with cerebrovascular disease. Neurology 34:736-740, 1984.

Ranze O, Ranze P, Magnani HN, Greinacher A. Heparin-induced thrombocytopenia in paediatrie patients—a review of the literature and a new case treated with danapar-oid sodium. Eur J Pediatr 158(suppl 3):S130-S133, 1999.

Ranze O, Rakow A, Ranze P, Eichler P, Greinacher A, Fusch C. Low dose danaparoid sodium catheter flushes in an intensive care infant suffering from heparin-induced thrombocytopenia. Pediatr Crit Care Med 2:175-177, 2001.

Rastellini C, Brown ML, Cicalese L. Heparin-induced thrombocytopenia following pancreatectomy and islet auto-transplantation. Clin Transplant 20:156-158, 2006.

Rhodes GR, Dixon RH, Silver D. Heparin-induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obslet 136:409-416,1973.

Rhodes GR. Dixon RH, Silver D. Heparin-induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Ann Surg 186:752-758, 1977.

Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 136:210-215, 2002.

Risch L, Pihan H, Zeller C, Huber AR. ET gets HIT-thrombocytotic heparin-induced thrombocytopenia (HIT) in a patient with essential thrombocythemia (ET). Blood Coagul Fibrinolysis 11:663-667, 2000.

Roberts B, Rosato FE, Rosato EF. Heparin—a cause of arterial emboli? Surgery 55: 803-808,1964.

Rowland CH, Woodford PA, De Lisle-Hammond J. Nair B. Heparin-induced thrombo-cytopenia: thrombosis syndrome and bilateral adrenal hemorrhage after prophylactic heparin use. Aust NZJ Med 29:741-742,1999.

Sauer M, Gruhn B, Fuchs D, Altermann WW, Greinacher A, Völpel H, Zintl F. Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid. Med Pediatr Oncol 32: 457-458,1999.

Scheffold N, Greinacher A, Cyran J. Intrakardiale Thrombenbildung bei Heparin-assoziierter Thrombozytopenie Typ II. Dtsch Med Wochenschr 1995; 120:519-522.

Shah MR, Spencer JP. Heparin-induced thrombocytopenia occurring after discontinuation of heparin. J Am Board Fam Pract 16:148-150, 2003.

Silver D, Kapsch DN, Tsoi EKM. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann Surg 198:301-306, 1983.

Smythe MA, Warkentin TE, Stephens JL, Zakalik D, Mattson JC. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia. Am J Hematol 71:50-52, 2002.

Smythe MA, Stephens JL, Mattson JC. Delayed-onset heparin-induced thrombocytope-nia. Ann Emerg Med 45:417-419, 2005.

Solomon SA, Cotton DWK, Preston FE, Ramsay LE. Severe disseminated intravascular coagulation associated with massive ventricular mural thrombus following acute myocardial infarction. Postgrad Med J 64:791-795, 1988.

Spadone D, Clark F, James E, Laster J, Hoch J, Silver D. Heparin-induced thrombocy-topenia in the newborn. J Vasc Surg 15:306-312, 1992.

Srinivasan AF, Rice L, Bartholomew JR, Rangaswamy C, La Perna L, Thompson JE, Murphy S, Baker KR. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med 164:66-70, 2004.

Stevenson MM. Thrombocytopenia during heparin therapy [letter]. N Engl J Med 295: 1200-1201, 1976.

Tahata T, Miki S, Kusuhara K, Ueda Y, Okita Y, Matsuo S. [Delayed onset of heparin induced thrombocytopenia: a case report]. Nippon Kyobu Geka Gakkai Zasshi 40: 456-458, 1992.

Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 77:2641-2648, 1991.

Tezcan AZ, Tezcan H, Gastineau DA, Armitage JO, Haire WD. Heparin-induced thrombocytopenia after bone marrow transplantation: report of two cases. Bone Marrow Transplant 14:487-490, 1994.

Theuerkauf I, Lickfett L, Harbrecht U, Pohl C, Fischer HP, Pfeifer U. Segmental hepatic vein thrombosis associated with heparin-induced thrombocytopenia II. Virchows Arch 436:88-91, 2000.

Tholl U, Greinacher A, Overdick K, Anlauf M. Life-threatening anaphylactic reaction following parathyroidectomy in a dialysis patient with heparin-induced thrombocy-topenia. Nephrol Dial Transplant 12:2750-2755,1997.

Thomas D, Block AJ. Thrombocytopenia, cutaneous necrosis, and gangrene of the upper and lower extremities in a 35-year-old man. Chest 102:1578-1580,1992.

Tietge UJF, Schmidt HH, Jäckel C, Trautwein C, Manns MP. LMWH-induced skin necrosis occurring distant from injection sites and without thrombocytopenia. J Intern Med 243:313-315, 1998.

Towne JB, Bernhard VM, Hussey C, Garancis JC. White clot syndrome. Peripheral vascular complications of heparin therapy. Arch Surg 114:372-377, 1979.

Van der Weyden MB, Hunt H, McGrath K, Fawcett T, Fitzmaurice A, Sawers RJ, Rosengarten DS. Delayed-onset heparin-induced thrombocytopenia. A potentially malignant syndrome. Med J Aust 2:132-135, 1983.

Vazquez-Jimenez JF, Janssens U, Sellhaus B, Hermanns B, Huegel W, Hanrath P, Messmer BJ. Thrombosis of a mitral valve prosthesis in a patient with heparin-induced thrombocytopenia type II. J Thorac Cardiovasc Surg 118:751-753,1999.

Vella A, Nippoldt TB, Morris JC III. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc 76:161-168, 2001.

Vignon P, Gueret P, Francois B, Serhal C, Fermeaux V, Bensaid J. Acute limb ischemia and heparin-induced thrombocytopenia: the value of echocardiography in eliminating a cardiac source of arterial emboli. J Am Soc Echocardiogr 9:344-347, 1996.

Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 106:629-635, 1999.

Warkentin TE. Hemostasis and arteriosclerosis. Can J Cardiol 1995; 11(suppl C): 29C-34C.

Warkentin TE. Heparin-induced skin lesions. Br J Haematol 92:494-497, 1996a.

Warkentin TE. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin induced thrombocytopenia. Transfusion Med Rev 10:249-258, 1996b.

Warkentin TE. Heparin-induced thrombocytopenia, heparin-induced skin lesions, and arterial thrombosis. Thromb Haemost 77(suppl):562, 1997.

Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol 35(suppl 5):9-16, 1998a.

Warkentin TE. Limitations of conventional treatment options for heparin-induced thrombocytopenia. Semin Hematol 35(suppl 5):17-25, 1998b.

Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost 82(suppl):439-447, 1999.

Warkentin TE. Venous thromboembolism in heparin-induced thrombocytopenia. Curr Opin Pulm Med 6:343-351, 2000.

Warkentin TE. Heparin-induced thrombocytopenia. Curr Hematol Rep 1:63-72, 2002a.

Warkentin TE. Heparin-induced thrombocytopenia and the anesthesiologist. Can J Anesth 49(suppl):S36-S49, 2002b.

Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535-555, 2003.

Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytope-nia. Chest 127(2 suppl):35S-45S, 2005.

Warkentin TE. Think of HIT when thrombosis follows heparin. Chest 130:631-632, 2006a.

Warkentin TE. Should vitamin K be administered when HIT is diagnosed after administration of coumarin? J Thromb Haemost 4:894-896, 2006b.

Warkentin TE. Think of HIT. Hematology Am Soc Hematol Educ Program 408-414, 2006c.

Warkentin TE. Drug-induced immune-mediated thrombocytopenia: from purpura to thrombosis. N Engl J Med 356:891-893, 2007.

Warkentin TE, Bernstein RA. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin. N Engl J Med 348:1067-1069, 2003.

Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy 126(3 suppl):311S-337S, 2004.

Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced throm-bocytopenia. Curr Hematol Rep 2:148-157, 2003.

Warkentin TE, Kelton JG. Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H, ed. Low-Molecular-Weight Hepar-ins in Prophylaxis and Therapy of Thromboembolic Diseases. New York: Marcel Dekker, pp. 75-127, 1994.

Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 101:502-507, 1996.

Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286-1292, 2001a.

Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135:502-506, 2001b.

Warkentin TE, Soutar RL, Panju A, Ginsberg JS. Acute systemic reactions to intravenous bolus heparin therapy: characterization and relationship to heparin-induced thrombocytopenia [abstr]. Blood 80(suppl 1):160a, 1992.

Warkentin TE, Hirte HW, Anderson DR, Wilson WEC, O'Connell GJ, Lo RC. Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med 97:489-491, 1994.

Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335, 1995.

Warkentin TE, Elavathil LJ, Hayward CPM, Johnston MA, Russett JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocy-topenia. Ann Intern Med 127:804-812, 1997.

Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79:1-7, 1998.

Warkentin TE, Sikov WM, Lillicrap DP. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia. Am J Med 62:44-48, 1999.

Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703-1708, 2000.

Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 163:2518-2524, 2003.

Warkentin TE, Whitlock RP, Teoh KHT. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis. Am J Hematol 75:56-62, 2004.

Warkentin TE, Sheppard JI, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 146:341-346, 2005a.

Warkentin TE, Roberts RS, Hirsh J, Kelton JG. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome. A nested cohort study. Chest 127:1857-1861, 2005b.

Warkentin TE, Cook RJ, Marder VJ, Sheppard JI, Moore JC, Eriksson BI, Greinacher A, Kelton JG. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 106: 3791-3796, 2005c.

Warkentin TE, Sheppard JI, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 108:2937-2941, 2006.

Weismann RE, Tobin RW. Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219-227, 1958.

Wütschert R, Piletta P, Bounameaux H. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention. Drug Safety 20:515-525, 1999.

Zalcberg JR, McGrath K, Dauer R, Wiley SJ. Heparin-induced thrombocytopenia with associated disseminated intravascular coagulation. Br J Haematol 54:655-660, 1983.

Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2:2133-2137, 2004.

Allergic To Everything

Allergic To Everything

The human body And Todays chemical infested world. Here is a news flash You are not allergic to pollen, pet dander, or whatever it is that makes your body revolt Rather, your body just can not handle that one thing, what ever it is, anymore, due to the massive barrage of toxic chemicals you and everyone else are ingesting every single day.

Get My Free Audio and Ebook


Post a comment